Sulk, Mathias
Albers, Carolin C.
Wulf, Maria
Braun, Stephan A.
Hammers, Christoph M.
Heine, Guido
Funding for this research was provided by:
Universitätsklinikum Münster
Article History
Received: 19 June 2023
Accepted: 29 August 2023
First Online: 2 November 2023
Conflict of interest
: M. Sulk received honoraria and travel support from AstraZeneca, Bencard, BioCryst, CSL-Behring, HAL Allergy, Novartis, Sanofi, Takeda, Unna Academy outside the submitted work; memberships in ABD, AeDA, DGAKI, EAACI. S.A. Braun received honoraria and travel support from Almirall, Amgen, Beiersdorf, Kyowa Kirin, Lilly, L’Oréal, Novartis outside the submitted work; memberships in ADF, ADH, DDG, ISDP. Financial support received from the German Federal Ministry of Research and Education (FKZ: 16KISA115K, 01IS22004B) and the EU (FKZ: 16KISA115K) and Galderma. C.M. Hammers received honoraria from JJP Biologics, Argenx and viDATherapeutics outside of this work. Financial support received from Deutsche Forschungsgemeinschaft, Collaborative Research Center (CRC) 1526—Pathomechanisms of Antibody-mediated Autoimmunity (PANTAU)—Insights from Pemphigoid Diseases (Grant No.: 454193335), Project A05. Memberships in DGAKI, DgfI, ADF, DDG, ESDR, JSID. G. Heine received honoraria from Allergopharma, Abbvie, Biotest, Eli-Lilly and Sanofi outside this work; memberships in DGAKI, DDG, DgfI, BDG, ABD, DKG. Financial support received from Deutsche Forschungsgemeinschaft, Collaborative Research Center (CRC) 1526—Pathomechanisms of Antibody-mediated Autoimmunity (PANTAU)—Insights from Pemphigoid Diseases (Grant No.: 454193335), Project A02 and S01. Memberships in ABD, DGAKI, EAACI. C.C. Albers and M. Wulf declare that they have no competing interests.